Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30988% above fair value
$32.16+2.64 (+8.94%)
Close on Nov 18, 2026Market cap $1.21BP/E –Yield –
Harrow free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Harrow's free cash flow for the twelve months ending Jun 30, 2026 was $5.02M, up 97.3% year over year. For fiscal 2025 it was $42.98M. The highest annual figure on record is $42.98M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.98M | – |
| FY2024 | Dec 31, 2024 | -$23.80M | -1099.9% |
| FY2023 | Dec 31, 2023 | $2.38M | – |
| FY2022 | Dec 31, 2022 | -$892.00K | -127.1% |
| FY2021 | Dec 31, 2021 | $3.30M | – |
| FY2020 | Dec 31, 2020 | -$1.96M | – |
| FY2019 | Dec 31, 2019 | -$518.00K | – |
| FY2018 | Dec 31, 2018 | -$1.08M | – |
| FY2017 | Dec 31, 2017 | -$9.58M | – |
| FY2016 | Dec 31, 2016 | -$18.10M | – |
| FY2015 | Dec 31, 2015 | -$10.15M | – |
| FY2014 | Dec 31, 2014 | -$7.23M | – |
| FY2013 | Dec 31, 2013 | -$4.46M | – |
| FY2012 | Dec 31, 2012 | -$1.92M | – |
| FY2011 | Dec 31, 2011 | -$291.16K | – |
| FY2010 | Dec 31, 2010 | -$2.30M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$10.25M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.19M | -147.1% |
| Q4 FY2025 | Dec 31, 2025 | $8.07M | – |
| Q3 FY2025 | Sep 30, 2025 | $16.38M | +597.8% |
| Q2 FY2025 | Jun 30, 2025 | -$969.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $19.50M | – |
| Q4 FY2024 | Dec 31, 2024 | -$18.33M | -315.6% |
| Q3 FY2024 | Sep 30, 2024 | $2.35M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.09M | -171.6% |
| Q1 FY2024 | Mar 31, 2024 | -$4.72M | – |
| Q4 FY2023 | Dec 31, 2023 | $8.50M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.73M | – |
| Q2 FY2023 | Jun 30, 2023 | $4.32M | -6.2% |
| Q1 FY2023 | Mar 31, 2023 | -$8.71M | -1647.1% |
| Q4 FY2022 | Dec 31, 2022 | -$4.59M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.47M | – |
| Q2 FY2022 | Jun 30, 2022 | $4.60M | +7.2% |
| Q1 FY2022 | Mar 31, 2022 | $563.00K | -81.2% |
| Q4 FY2021 | Dec 31, 2021 | -$1.63M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.37M | -197.6% |
| Q2 FY2021 | Jun 30, 2021 | $4.29M | – |
| Q1 FY2021 | Mar 31, 2021 | $3.00M | – |
| Q4 FY2020 | Dec 31, 2020 | -$648.00K | -183.8% |
| Q3 FY2020 | Sep 30, 2020 | $2.42M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.97M | -703.0% |
| Q1 FY2020 | Mar 31, 2020 | -$770.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $773.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$94.00K | – |
| Q2 FY2019 | Jun 30, 2019 | $492.00K | -51.1% |
| Q1 FY2019 | Mar 31, 2019 | -$1.69M | – |
| Q4 FY2018 | Dec 31, 2018 | -$736.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$195.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $1.01M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.16M | – |
| Q4 FY2017 | Dec 31, 2017 | -$478.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.49M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.48M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.13M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.59M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.70M | – |
See a number that looks wrong?